Willow Grove, PA, Jan. 03, 2017 -- Azzur Group, LLC, a private equity firm with holdings in the life sciences consulting industry, is pleased to announce the acquisition of US-based training company, Learnaboutgmp.
Learnaboutgmp is an online training and education platform for biotechnology, pharmaceutical, and medical device companies. This platform has allowed some of the top international pharmaceutical companies to greatly increase their compliance knowledge and compliment their existing in-house training. The acquisition will allow Azzur Group to offer clients and competitors alike convenient and actionable training.
“We believe Learnaboutgmp is the resource that many companies have been looking for to add strength to their current team members and to allow members to grow in their career in the life science field,” said Thomas O’Donnell, Managing Partner of Azzur Group. "We are excited for the opportunities this new partnership will bring to our existing client base, and for the strength it will bring our incoming clients to bridge this talent gap.”
Visit Learnaboutgmp.com to find out more, and to sign up for a free 14 day trial and demo.
About Azzur Group, LLC- Azzur Group is a private equity firm comprised of a network of high-level life science companies, created to provide efficient and cost-effective solutions. As one of the fastest-growing, private companies in America, Azzur is firmly focused on providing seamless service to our customers. Our team of experienced industry professionals serves the pharmaceutical, biotechnology, and medical device industry by providing one-stop access to a wide-range of project management, process engineering, and compliance services within the life science industry.
About Learnaboutgmp- Learnaboutgmp is a cloud-based learning management system (LMS) designed specifically for life science and regulatory organizations. Our LMS contains the courses you need to help you achieve regulatory compliance. With new courses published every month and existing courses updated in line with regulatory changes, we are your true continuous learning platform.
“Learnaboutgmp’s content is developed by leading subject experts resulting in courses that are current, relevant and meaningful to learners. Every course was given a huge thumbs up by our internal Quality Systems leaders. Hands down, working with Learnaboutgmp has been one of the best engagements we have had in over 18 years of managing vendor course content and relationships. I highly recommend them to any Pharma organization interested in deploying top notch GMP related courseware.”
- VP, Global Quality Learning Top 5 Pharma Company
Graham O’Keeffe CEO [email protected] 4315 Independence Drive Schnecksville, PA, 18078 USA 315.636.4782


FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 



